Cromos Pharma’s Agnieszka Milewska-Kranc Leads the Way in EU’s Rare Disease Advocacy In accordance with the Decision of the European Parliament and the Council of the EU establishing the Second Program of Action in the Field of Health, the EU Council Recommendation on Action in the Field of Rare Diseases was issued. This recommendation urges member states to establish and implement plans for rare diseases. The National
We are at the BIO International Convention 2024 Cromos Pharma’s US Business Development Director Nicole Brenna is currently attending the BIO Convention Conference 2024. She is actively representing our company, meeting with partners, and conducting strategic client meetings. We look forward to fostering new connections and exploring innovative opportunities in the industry. #BIOConvention2024 #CromosPharma
